https://pubmed.sekgen.xyz
Publication trend analytics from PubMed and OpenAlex, payable per-query via x402 in USDC on Base.
| endpoint | price | |
|---|---|---|
| /api/v1/explore | $0.10 | Cross-domain discovery or MeSH anomaly detection |
| /api/v1/emerging | $0.05 | Topics with accelerating multi-year growth |
| /api/v1/hottest-weekly | $0.05 | Topics spiking this week vs recent average |
| /api/v1/trending-subtopics | $0.05 | Rising sub-topics within a research field |
| /api/v1/trends | $0.01 | Year-by-year publication counts and analytics |
| /api/v1/compare | $0.02 | Compare trends across 2-5 terms |
| /api/v1/pulse | $0.02 | 7d/30d/90d publication volume with YoY change |
| /api/v1/snapshot | $0.01 | Single-year publication count |
| /api/v1/keypapers | $0.03 | Scored key papers for a query |
| /api/v1/digest | $0.08 | Key papers + MeSH landscape + frequent authors |
| /api/v1/author | $0.02 | Researcher profile from OpenAlex |
| question | endpoint |
|---|---|
| What's interesting? (no prior knowledge) | /explore — cross-domain discovery |
| What's growing fast from a small base? | /emerging — CAGR over 3 years, catches new/niche fields |
| What's spiking right now? | /hottest-weekly — current vs last year pace, any field size |
| What sub-topics within this field are rising? | /trending-subtopics — intra-field growth from OpenAlex |
| How has this topic evolved over time? | /trends — year-by-year counts and analytics |
| How do these topics compare? | /compare — side-by-side trends with crossover detection |
| Is there a surge happening now? | /pulse — 7d/30d/90d volumes vs year ago |
| Quick count for one year? | /snapshot — low-cost single data point |
| What are the key papers? | /keypapers — scored by journal, type, MeSH relevance |
| Give me the full picture | /digest — papers + MeSH + authors in one call |
| Who is this researcher? | /author — h-index, works, topics, institution |
/emerging works best for niche/new topics. Returns empty for mature fields — use /hottest-weekly instead. When source=openalex, both accept free-text topic searches.
topics param.| param | required | default | |
|---|---|---|---|
| topics | no | Comma-separated domains, max 4. Present: OpenAlex. Absent: MeSH anomalies | |
| limit | no | 5 | Max results (1-20) |
| min_z_score | no | 2.0 | Z-score threshold (anomaly mode only) |
| days | no | 7 | Recent window, 1-30 (anomaly mode only) |
GET /api/v1/explore?topics=neurodegeneration,epigenetics&limit=5
GET /api/v1/explore?limit=3
category for PubMed mode (default) or topic + source=openalex for free-text search.| param | required | default | |
|---|---|---|---|
| category | no | oncology, neuroscience, immunology, gene therapy, cardiology. Required for PubMed mode | |
| topic | no | Free-text search. Required for OpenAlex mode | |
| source | no | pubmed | pubmed or openalex |
| window_years | no | 3 | Years to evaluate |
| min_growth_rate | no | 1.0 / 0.3 | Min CAGR (PubMed / OpenAlex default) |
| limit | no | 10 | Max results |
GET /api/v1/emerging?category=oncology&min_growth_rate=0.5
GET /api/v1/emerging?topic=CRISPR&source=openalex
category for PubMed mode (default) or topic + source=openalex for free-text search.| param | required | default | |
|---|---|---|---|
| category | no | oncology, neuroscience, immunology, gene therapy, cardiology. Required for PubMed mode | |
| topic | no | Free-text search. Required for OpenAlex mode | |
| source | no | pubmed | pubmed or openalex |
GET /api/v1/hottest-weekly?category=oncology
GET /api/v1/hottest-weekly?topic=microbiome&source=openalex
| param | required | default | |
|---|---|---|---|
| query | yes | Free-text search defining the field | |
| limit | no | 10 | Max results (1-25) |
| window | no | 3 | Years of history (2-5) |
GET /api/v1/trending-subtopics?query=ulcerative+colitis&limit=10
| param | required | default | |
|---|---|---|---|
| query | yes | PubMed search query | |
| start_year | no | -10y | First year |
| end_year | no | now | Last year |
GET /api/v1/trends?query=CRISPR&start_year=2018&end_year=2025
| param | required | default | |
|---|---|---|---|
| terms | yes | Comma-separated, 2-5 terms | |
| start_year | no | -10y | First year |
| end_year | no | now | Last year |
GET /api/v1/compare?terms=CAR-T,bispecific+antibodies&start_year=2018
| param | required | default | |
|---|---|---|---|
| query | yes | PubMed search query |
GET /api/v1/pulse?query=CRISPR
| param | required | default | |
|---|---|---|---|
| query | yes | PubMed search query | |
| year | no | now | Year to count |
GET /api/v1/snapshot?query=mRNA+vaccine&year=2025
| param | required | default | |
|---|---|---|---|
| query | yes | PubMed search query | |
| start_year | no | -5y | First year |
| end_year | no | now | Last year |
GET /api/v1/keypapers?query=base+editing&start_year=2023&end_year=2025
| param | required | default | |
|---|---|---|---|
| query | yes | PubMed search query | |
| start_year | no | -5y | First year |
| end_year | no | now | Last year |
GET /api/v1/digest?query=base+editing&start_year=2023&end_year=2025
name or orcid.| param | required | default | |
|---|---|---|---|
| name | no | Author name search | |
| orcid | no | ORCID identifier |
One of name or orcid is required.
GET /api/v1/author?name=David+Liu
All /api/v1/* routes return 402 without a valid payment. Your x402 client reads the payment requirements from the response, signs a USDC transfer on Base, and retries with an X-PAYMENT header.
awal x402 pay "https://pubmed.sekgen.xyz/api/v1/trends?query=CRISPR"
Or programmatically with @x402/fetch.
Step 1 — Call /trends or /pulse ($0.01–$0.02) to identify a trend.
Step 2 — Call /digest ($0.08) for scored papers, MeSH landscape, and authors.
Step 3 — Pass returned PMIDs to PubMed MCP get_article_metadata for full abstracts.
Step 1 — Call /hottest-weekly for all 5 categories ($0.25) to find spiking topics.
Step 2 — Call /pulse on the 2 standout topics ($0.04) for year-over-year context.
Step 3 — Synthesize into a briefing.
See more examples with real API response data →
| status | |
|---|---|
| 400 | Missing or invalid parameters |
| 402 | Payment required |
| 502 | Upstream API error (NCBI or OpenAlex) |
Valid values for category in /emerging and /hottest-weekly (PubMed mode):
oncology: CAR-T cell therapy, bispecific antibodies, antibody drug conjugate, immune checkpoint inhibitor, ctDNA liquid biopsy, tumor infiltrating lymphocytes, oncolytic virus therapy, cancer neoantigen vaccine, KRAS inhibitor, CDK4/6 inhibitor, PARP inhibitor, radiopharmaceutical therapy, chimeric antigen receptor NK cell, cancer organoid, spatial transcriptomics cancer, ctDNA minimal residual disease, tumor treating fields, cancer ferroptosis, circular RNA cancer biomarker, artificial intelligence drug resistance cancer, single cell proteomics tumor, cancer extracellular vesicle liquid biopsy, photoimmunotherapy cancer, PROTAC degrader oncology, tumor microbiome
neuroscience: anti-amyloid antibody, tau PET imaging, CGRP antagonist migraine, deep brain stimulation, brain-computer interface, optogenetics therapy, antisense oligonucleotide neurodegeneration, psychedelic assisted psychotherapy, GLP-1 agonist neurodegeneration, alpha-synuclein antibody, gene therapy spinal muscular atrophy, focused ultrasound brain, neuroinflammation biomarker, digital phenotyping mental health, closed-loop neurostimulation, focused ultrasound blood brain barrier, psychedelic neuroplasticity, gut brain axis microbiome, AI drug discovery neurodegeneration, digital biomarker cognition, brain organoid disease model, glymphatic system sleep, CRISPR neurological disorder, senolytic neurodegeneration, neuroimmune interaction microglia
immunology: mRNA vaccine, CAR-T autoimmune, regulatory T cell therapy, IL-17 inhibitor, JAK inhibitor, bispecific antibody autoimmune, tolerogenic dendritic cell, complement inhibitor, microbiome immunotherapy, IgG4 related disease, thymic stromal lymphopoietin, chimeric autoantibody receptor, B cell depletion autoimmune, innate lymphoid cell, trained immunity, mRNA cancer vaccine, CRISPR T cell engineering, IL-33 pathway, trained immunity epigenetic, immune checkpoint autoimmune, single cell immune profiling, nanoparticle vaccine adjuvant, mucosal immunity mRNA, immune aging immunosenescence, spatial transcriptomics immune
gene therapy: CRISPR gene editing, base editing, prime editing, AAV gene therapy, lipid nanoparticle mRNA, epigenome editing, in vivo gene editing, RNA interference therapeutic, gene therapy hemophilia, gene therapy sickle cell, CRISPR diagnostics, gene drive, synthetic biology therapeutic, cell-free DNA therapeutic, tRNA therapeutic, epigenetic editing, in vivo base editing, lipid nanoparticle delivery optimization, RNA editing ADAR, programmable RNA medicine, circular RNA therapeutic, self-amplifying RNA, gene therapy retinal dystrophy, meganuclease gene correction, extracellular vesicle gene delivery
cardiology: PCSK9 inhibitor, SGLT2 inhibitor heart failure, GLP-1 agonist cardiovascular, cardiac gene therapy, RNA therapeutics cardiovascular, artificial heart, transcatheter valve replacement, cardiac regeneration stem cell, lipoprotein(a) inhibitor, myosin inhibitor cardiac, cardiac digital twin, wearable ECG monitoring, AI cardiac imaging, cardiac organoid, inflammasome inhibitor cardiovascular, cardiac patch tissue engineering, AI ECG screening, gut microbiome cardiovascular, clonal hematopoiesis cardiovascular, cardiac fibrosis reversal, siRNA cardiovascular therapeutic, remote cardiac monitoring wearable, perivascular adipose tissue, cardiac reprogramming direct, CRISPR cardiovascular disease
Data from NCBI PubMed and OpenAlex. Yearly data cached 24h, daily-resolution data cached 6h.